<![CDATA[Genmab — Maj 2025]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/topic/399196/genmab-maj-2025RSS for NodeSun, 07 Jun 2026 04:30:45 GMTThu, 01 May 2025 01:35:51 GMT60<![CDATA[Reply to Genmab — Maj 2025 on Sat, 31 May 2025 05:35:26 GMT]]>Lymphoma Hub
@lymphomahub
CONGRESS | #ASCO25 | PRESENTATION
@DrJulieVose

shares insights on incorporating epcoritamab into clinical practice for the treatment of patients with R/R FL.
They highlight results from the pivotal FL cohort of the EPCORE NHL-1 trial (N = 128) and discuss key considerations for monitoring in the outpatient setting. https://x.com/lymphomahub/status/1928522519759270376 https://x.com/VJHemOnc/status/1928525984988360814

]]>https://dev.proinvestor.com/forum/post/7684141https://dev.proinvestor.com/forum/post/7684141Sat, 31 May 2025 05:35:26 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 20:42:24 GMT]]>Gen fylder skræmmende 33% i portefølje
med mine frie midler. Dog overgået af vws, ligeså skræmmende.. først blevet novo aktionær indenfor den sidste måneds tid..

]]>https://dev.proinvestor.com/forum/post/7684138https://dev.proinvestor.com/forum/post/7684138Fri, 30 May 2025 20:42:24 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 16:24:26 GMT]]>Mine to største positioner er, Novo og Genmab, ca lige store og tilsammen 40%.
Jeg sidder og gætter på, hvilken, der hurtigst fordobles. De har jo begge været over dobbelt så dyre, som de er nu.

]]>https://dev.proinvestor.com/forum/post/7684142https://dev.proinvestor.com/forum/post/7684142Fri, 30 May 2025 16:24:26 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 15:48:46 GMT]]>100% i de sidste ca. 20 år. Er godt tilfreds, mit bedste køb var til 35.60 kr. Er rimelig sikker på at det er et godt køb til den nuværende kurs, men det kræver sikkert god tå
lmodighed.

]]>https://dev.proinvestor.com/forum/post/7684143https://dev.proinvestor.com/forum/post/7684143Fri, 30 May 2025 15:48:46 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 14:20:22 GMT]]>Et åbent spørgsmål.. Hvor meget fylder Genmab af jeres portefølje?.. Jeg sidder og tænker over, om man bør hælde mere i Genmab til disse kurser - måske forsøge og fange hvis den tager et dyk til ned omkring 1200.. Pt. fylder Genmab godt 3-4% hvilket er meget normalt hos mig for enkeltaktier..

]]>https://dev.proinvestor.com/forum/post/7684139https://dev.proinvestor.com/forum/post/7684139Fri, 30 May 2025 14:20:22 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 11:46:43 GMT]]>Acasunlimab konkurrent viser svaghedstegn.

]]>https://dev.proinvestor.com/forum/post/7684140https://dev.proinvestor.com/forum/post/7684140Fri, 30 May 2025 11:46:43 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 11:46:00 GMT]]>Det rammer også Biontech. Hvorvidt Regeneron også satser på denne bispecific er jeg ikke klar over. Men flere selskaber har sat store forventninger netop til dette.

]]>https://dev.proinvestor.com/forum/post/7684133https://dev.proinvestor.com/forum/post/7684133Fri, 30 May 2025 11:46:00 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 11:43:48 GMT]]>Summets PD1 x EGFR bispecifik fejlede endpoint OS i fase 3 https://finance.yahoo.com/news/ivonescimab-plus-chemotherapy-demonstrates-statistically-100000274.html

]]>https://dev.proinvestor.com/forum/post/7684136https://dev.proinvestor.com/forum/post/7684136Fri, 30 May 2025 11:43:48 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 11:38:51 GMT]]>great start of ASCO for Biontech, -5%, Sanofi, -6%, Regeneron, -18% and Summit -24%, dragging this disastrous sector down again 😞

]]>https://dev.proinvestor.com/forum/post/7684134https://dev.proinvestor.com/forum/post/7684134Fri, 30 May 2025 11:38:51 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 04:19:09 GMT]]>God morgen 🙂

]]>https://dev.proinvestor.com/forum/post/7684137https://dev.proinvestor.com/forum/post/7684137Fri, 30 May 2025 04:19:09 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 03:48:42 GMT]]>God morgen 🙂

]]>https://dev.proinvestor.com/forum/post/7684135https://dev.proinvestor.com/forum/post/7684135Fri, 30 May 2025 03:48:42 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 03:11:43 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/7684130https://dev.proinvestor.com/forum/post/7684130Fri, 30 May 2025 03:11:43 GMT<![CDATA[Reply to Genmab — Maj 2025 on Fri, 30 May 2025 03:00:18 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/7684128https://dev.proinvestor.com/forum/post/7684128Fri, 30 May 2025 03:00:18 GMT<![CDATA[Reply to Genmab — Maj 2025 on Thu, 29 May 2025 10:38:27 GMT]]>Maj Status: NVIDIA, toldsatser, Novo, Zealand Pharma, Gubra, Genmab, Embla Kort video: https://proinvestor.com/boards/126575

]]>https://dev.proinvestor.com/forum/post/7684125https://dev.proinvestor.com/forum/post/7684125Thu, 29 May 2025 10:38:27 GMT<![CDATA[Reply to Genmab — Maj 2025 on Wed, 28 May 2025 17:22:59 GMT]]>ABBV-400 stammer fra Immunogen købet til $10bn. ABBV-400 har DAR 6 og artiklen der er linket til nævner SAE som noget vi skal holde øje med https://www.oncologypipeline.com/apexonco/asco-2024-preview-jury-still-out-abbvies-cancer-push Husk at Elahere som også kommer fra nævnte køb også har problematiske SAE (2% fatale). Rina-S er konkurrent til Elahere. Sandelig spændende for Abbvie 🙂

]]>https://dev.proinvestor.com/forum/post/7684126https://dev.proinvestor.com/forum/post/7684126Wed, 28 May 2025 17:22:59 GMT<![CDATA[Reply to Genmab — Maj 2025 on Wed, 28 May 2025 16:52:58 GMT]]>Genmab arbejder med samme indikationer med acasunlimab og nok mere sammenligneligt med deres ADC stof fra Profound - GEN1286

]]>https://dev.proinvestor.com/forum/post/7684127https://dev.proinvestor.com/forum/post/7684127Wed, 28 May 2025 16:52:58 GMT<![CDATA[Reply to Genmab — Maj 2025 on Wed, 28 May 2025 16:48:07 GMT]]>Abbvie arbejder med nye payloads med bedre virkning deres allerede godkendte EMRELIS™ (telisotuzumab vedotin-tllv). Nyt stof ABBV-
400 (Telisotuzumab adizutecan) er værd at følge https://news.abbvie.com/2025-05-27-AbbVie-Features-New-Data-Across-Difficult-to-Treat-Solid-Tumors-and-Blood-Cancers-at-ASCO-2025,-Highlighting-Breadth-and-Depth-of-its-Oncology-Portfolio

]]>https://dev.proinvestor.com/forum/post/7684131https://dev.proinvestor.com/forum/post/7684131Wed, 28 May 2025 16:48:07 GMT<![CDATA[Reply to Genmab — Maj 2025 on Wed, 28 May 2025 08:33:15 GMT]]>probably
not yet; the status is still 'recruiting' and 2 recruitment centers were just added

]]>https://dev.proinvestor.com/forum/post/7684121https://dev.proinvestor.com/forum/post/7684121Wed, 28 May 2025 08:33:15 GMT<![CDATA[Reply to Genmab — Maj 2025 on Wed, 28 May 2025 07:54:13 GMT]]>Do we know if all patients have been enrolled?

]]>https://dev.proinvestor.com/forum/post/7684122https://dev.proinvestor.com/forum/post/7684122Wed, 28 May 2025 07:54:13 GMT<![CDATA[Reply to Genmab — Maj 2025 on Wed, 28 May 2025 07:00:57 GMT]]>It would be nice i their laser sharp focus for once would be positive...

]]>https://dev.proinvestor.com/forum/post/7684118https://dev.proinvestor.com/forum/post/7684118Wed, 28 May 2025 07:00:57 GMT<![CDATA[Reply to Genmab — Maj 2025 on Wed, 28 May 2025 06:59:34 GMT]]>As the 1057 study is a small phase 1 FIH study the goal is not to look at long term data so in a sense only positive if they can reach conclusions a bit sooner, I guess

]]>https://dev.proinvestor.com/forum/post/7684119https://dev.proinvestor.com/forum/post/7684119Wed, 28 May 2025 06:59:34 GMT<![CDATA[Reply to Genmab — Maj 2025 on Tue, 27 May 2025 11:27:01 GMT]]>GEN1057 moves expected completion dates a year earlier, never really know what it means; either recruitment is going superfast or patients can stay on the drug much shorter as anticipated... anyway, we'll know earlier https://clinicaltrials.gov/study/NCT06573294?tab=history&a=7&b=8#version-content-panel

]]>https://dev.proinvestor.com/forum/post/7684123https://dev.proinvestor.com/forum/post/7684123Tue, 27 May 2025 11:27:01 GMT<![CDATA[Reply to Genmab — Maj 2025 on Sat, 24 May 2025 09:25:23 GMT]]>Genmabs fremtidige salg af epcoritamab https://proinvestor.com/boards/126539

]]>https://dev.proinvestor.com/forum/post/7684129https://dev.proinvestor.com/forum/post/7684129Sat, 24 May 2025 09:25:23 GMT<![CDATA[Reply to Genmab — Maj 2025 on Sat, 24 May 2025 07:12:35 GMT]]>@EL thank you so much.

]]>https://dev.proinvestor.com/forum/post/7684124https://dev.proinvestor.com/forum/post/7684124Sat, 24 May 2025 07:12:35 GMT